{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:57:01Z","timestamp":1781643421981,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00dcB\u0130TAK","doi-asserted-by":"crossref","award":["T\u00dcB\u0130TAK-1002;Project number:223S035"],"award-info":[{"award-number":["T\u00dcB\u0130TAK-1002;Project number:223S035"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute hepatic porphyria (AHP) is a heme metabolism disorder characterized by acute abdominal pain episodes, with diagnostic delays and misdiagnosis due to heterogeneous presentations and symptom overlap with other diseases. Timely diagnosis is crucial as untreated attacks can lead to life-threatening complications such as hepatocellular carcinoma, chronic kidney disease, neuropathy and chronic pain. AHP often mimics various conditions such as lead poisoning, Guillain-Barr\u00e9 syndrome, vasculitis and surgical abdominal conditions, leading to diagnostic challenges and inappropriate treatment. Familial Mediterranean fever (FMF), another disease with recurrent abdominal pain as its main feature, has a similar symptomatology to AHP. The aim of this study was to investigate the prevalence of AHP in patients with clinically suspected FMF without a confirmatory genotype using cross-sectional urinary porphobilinogen (PBG) screening during abdominal pain episodes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This cross-sectional study included a total of 104 patients under rheumatology follow-up for suspected FMF and two control groups (genetically confirmed FMF patients and healthy controls). Patients presenting with severe abdominal pain and had a spot urinary PBG\/creatinine ratio of \u2265\u200910 \u00b5mol\/mmol were diagnosed with AHP together with at least one clinical manifestation defined by the European Porphyria Network. Among 104 suspected-FMF patients, 5 (4.8%) were diagnosed with AHP, with a diagnostic delay of 16.4\u2009\u00b1\u200910.38 years. AHP patients frequently exhibited neurological (muscle weakness, paresthesia), psychiatric, and gastrointestinal (nausea, vomiting) symptoms. In likelihood ratio analyses, urinary incontinence, hypertension and neuropathic symptoms were strong discriminative indicators of AHP, whereas fever, arthritis, rash and chest pain were more indicative of FMF, aiding differential diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Due to diagnostic challenges and overlapping symptoms, AHP should be considered in the differential diagnosis of FMF, particularly in patients with neurological or systemic features. Urinary PBG screening and identifying predictive markers may improve diagnostic accuracy and early management of AHP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04308-3","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:55:09Z","timestamp":1773917709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Acute hepatic porphyria masquerading as familial Mediterranean fever: results of a cross-sectional porphobilinogen screening"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2896-6327","authenticated-orcid":false,"given":"Gulustan","family":"Musayeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7487-1376","authenticated-orcid":false,"given":"Esra","family":"\u0130\u015fat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7834-4909","authenticated-orcid":false,"given":"Mehmet","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3315-5124","authenticated-orcid":false,"given":"Mehmet \u015eerif","family":"Cansever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9561-2282","authenticated-orcid":false,"given":"Serdal","family":"U\u011furlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0495-6152","authenticated-orcid":false,"given":"Dilek Uluda\u011f","family":"Alkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5365-3457","authenticated-orcid":false,"given":"Sezgin","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8459-2872","authenticated-orcid":false,"given":"Kenan","family":"Barut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5170-5594","authenticated-orcid":false,"given":"Ertu\u011frul","family":"K\u0131yk\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7256-0750","authenticated-orcid":false,"given":"\u00c7i\u011fdem","family":"Aktu\u011flu-Zeybek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1125-7720","authenticated-orcid":false,"given":"\u00d6zg\u00fcr","family":"Kasap\u00e7opur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7159-4008","authenticated-orcid":false,"given":"Tanyel","family":"Zubarioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"4308_CR1","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","volume":"375","author":"H Puy","year":"2010","unstructured":"Puy H, Gouya L, Deybach JC, Porphyrias. Lancet. 2010;375:924\u201337. https:\/\/doi.org\/10.1016\/S0140-6736(09)61925-5.","journal-title":"Lancet"},{"key":"4308_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(05)17744-7","volume":"365","author":"R Kauppinen","year":"2005","unstructured":"Kauppinen R, Porphyrias. Lancet. 2005;365:241\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(05)17744-7.","journal-title":"Lancet"},{"key":"4308_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5152\/TurkArchPediatr.2022.22301","volume":"58","author":"T Z\u00fcbario\u011flu","year":"2023","unstructured":"Z\u00fcbario\u011flu T, K\u0131yk\u0131m E, Aktu\u011flu-Zeybek \u00c7. An overview of acute hepatic porphyrias: Clinical implications, diagnostic approaches, and management strategies. Turk Arch Pediatr. 2023;58:3\u20139. https:\/\/doi.org\/10.5152\/TurkArchPediatr.2022.22301.","journal-title":"Turk Arch Pediatr"},{"key":"4308_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ymgme.2019.04.008","volume":"128","author":"JD Phillips","year":"2019","unstructured":"Phillips JD. Heme biosynthesis and the porphyrias. Mol Genet Metab. 2019;128:164\u201377. https:\/\/doi.org\/10.1016\/j.ymgme.2019.04.008.","journal-title":"Mol Genet Metab"},{"key":"4308_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ymgme.2019.03.002","volume":"128","author":"HL Bonkovsky","year":"2019","unstructured":"Bonkovsky HL, Dixon N, Rudnick S. Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs). Mol Genet Metab. 2019;128:213\u20138. https:\/\/doi.org\/10.1016\/j.ymgme.2019.03.002.","journal-title":"Mol Genet Metab"},{"key":"4308_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/BF03401859","volume":"7","author":"MM Schuurmans","year":"2001","unstructured":"Schuurmans MM, Schneider-Yin X, R\u00fcfenacht UB, Schnyder C, Minder CE, Puy H, et al. Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients. Mol Med. 2001;7:535\u201342.","journal-title":"Mol Med"},{"key":"4308_CR7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/imj.12784","volume":"45","author":"A Ahangari","year":"2015","unstructured":"Ahangari A, B\u00e4ckstr\u00f6m T, Innala E, Andersson C, Turkmen S. Acute intermittent porphyria symptoms during the menstrual cycle. Intern Med J. 2015;45:725\u201331. https:\/\/doi.org\/10.1111\/imj.12784.","journal-title":"Intern Med J"},{"key":"4308_CR8","doi-asserted-by":"publisher","first-page":"CD01","DOI":"10.7860\/JCDR\/2014\/10597.5315","volume":"8","author":"LN Akshatha","year":"2014","unstructured":"Akshatha LN, Rukmini MS, Shenoy MT, Saashiva Rao P, Prashanth B. Lead poisoning mimicking acute porphyria! J Clin Diagn Res. 2014;8:CD01\u201302. https:\/\/doi.org\/10.7860\/JCDR\/2014\/10597.5315.","journal-title":"J Clin Diagn Res"},{"key":"4308_CR9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1186\/s13104-018-3615-z","volume":"11","author":"NLR Indika","year":"2018","unstructured":"Indika NLR, Kesavan T, Dilanthi HW, Jayasena KLSPKM, Chandrasiri NDPD, Jayasinghe IN, et al. Many pitfalls in diagnosis of acute intermittent porphyria: a case report. BMC Res Notes. 2018;11:552. https:\/\/doi.org\/10.1186\/s13104-018-3615-z.","journal-title":"BMC Res Notes"},{"key":"4308_CR10","doi-asserted-by":"publisher","first-page":"e2389","DOI":"10.1002\/brb3.2389","volume":"11","author":"LM Gerischer","year":"2021","unstructured":"Gerischer LM, Scheibe F, N\u00fcmann A, K\u00f6hnlein M, St\u00f6lzel U, Meisel A. Acute porphyrias - A neurological perspective. Brain Behav. 2021;11:e2389. https:\/\/doi.org\/10.1002\/brb3.2389.","journal-title":"Brain Behav"},{"key":"4308_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.7196\/SAMJ.2016.v106i1.10118","volume":"106","author":"CM Schutte","year":"2015","unstructured":"Schutte CM, van der Meyden CH, van Niekerk L, Kakaza M, van Coller R, Ueckermann V, et al. Severe porphyric neuropathy\u2013importance of screening for porphyria in Guillain-Barr\u00e9 syndrome. S Afr Med J. 2015;106:44\u20137. https:\/\/doi.org\/10.7196\/SAMJ.2016.v106i1.10118.","journal-title":"S Afr Med J"},{"key":"4308_CR12","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1053\/j.gastro.2022.11.034","volume":"164","author":"B Wang","year":"2023","unstructured":"Wang B, Bonkovsky HL, Lim JK, Balwani M, AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias. Expert Rev Gastroenterol. 2023;164:484\u201391. https:\/\/doi.org\/10.1053\/j.gastro.2022.11.034.","journal-title":"Expert Rev Gastroenterol"},{"key":"4308_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ymgme.2019.07.002","volume":"128","author":"KE Anderson","year":"2019","unstructured":"Anderson KE. Acute hepatic porphyrias: Current diagnosis & management. Mol Genet Metab. 2019;128:219\u201327. https:\/\/doi.org\/10.1016\/j.ymgme.2019.07.002.","journal-title":"Mol Genet Metab"},{"key":"4308_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/0004563216667965","volume":"54","author":"J Woolf","year":"2017","unstructured":"Woolf J, Marsden JT, Degg T, Whatley S, Reed P, Brazil N, et al. Best practice guidelines on first-line laboratory testing for porphyria. Ann Clin Biochem. 2017;54:188\u201398. https:\/\/doi.org\/10.1177\/0004563216667965.","journal-title":"Ann Clin Biochem"},{"key":"4308_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.5606\/tjr.2012.049","volume":"27","author":"F Akt\u00fcrk","year":"2012","unstructured":"Akt\u00fcrk F, \u00c7al\u0131\u015fkan Y, Esen B. Coexistence of Familial Mediterranean Fever and Acute Intermittent Porphyria. Archives Rheumatol. 2012;27:271\u201372. https:\/\/doi.org\/10.5606\/tjr.2012.049.","journal-title":"Archives Rheumatol"},{"key":"4308_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/ndtplus\/sfq211","volume":"4","author":"JR Delanghe","year":"2011","unstructured":"Delanghe JR, Speeckaert MM. Creatinine determination according to Jaffe-what does it stand for? NDT Plus. 2011;4:83\u20136. https:\/\/doi.org\/10.1093\/ndtplus\/sfq211.","journal-title":"NDT Plus"},{"key":"4308_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1515\/bchm1.1886.10.5.391","volume":"10","author":"M Jaffe","year":"1886","unstructured":"Jaffe M. Ueber den Niederschlag, welchen Pikrins\u00e4ure in normalem Harn erzeugt und \u00fcber eine neue Reaction des Kreatinins. Biol Chem. 1886;10:391\u2013400. https:\/\/doi.org\/10.1515\/bchm1.1886.10.5.391.","journal-title":"Biol Chem"},{"key":"4308_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1515\/bchm2.1904.41.3.223","volume":"41","author":"O Folin","year":"1904","unstructured":"Folin O. Beitrag zur Chemie des Kreatinins und Kreatins im Harne. Biol Chem. 1904;41:223\u201342. https:\/\/doi.org\/10.1515\/bchm2.1904.41.3.223.","journal-title":"Biol Chem"},{"key":"4308_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/00365510802149978","volume":"241","author":"M Panteghini","year":"2008","unstructured":"Panteghini M. Enzymatic assays for creatinine: time for action. Scand J Clin Lab Invest Suppl. 2008;241:84\u20138. https:\/\/doi.org\/10.1080\/00365510802149978.","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"4308_CR20","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/jimd.12612","volume":"46","author":"PE Stein","year":"2023","unstructured":"Stein PE, Edel Y, Mansour R, Mustafa RA, Sandberg S, Members of the Acute Porphyria Expert Panel. Key terms and definitions in acute porphyrias: Results of an international Delphi consensus led by the European porphyria network. J Inherit Metab Dis. 2023;46:662\u201374. https:\/\/doi.org\/10.1002\/jimd.12612.","journal-title":"J Inherit Metab Dis"},{"key":"4308_CR21","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.3390\/diagnostics11122324","volume":"11","author":"A Ricci","year":"2021","unstructured":"Ricci A, Guida CC, Manzini P, Cuoghi C, Ventura P. Kidney Involvement in Acute Hepatic Porphyrias: Pathophysiology and Diagnostic Implications. Diagnostics (Basel). 2021;11:2324. https:\/\/doi.org\/10.3390\/diagnostics11122324.","journal-title":"Diagnostics (Basel)"},{"key":"4308_CR22","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.3390\/cancers14122947","volume":"14","author":"D Ramai","year":"2022","unstructured":"Ramai D, Deliwala SS, Chandan S, Lester J, Singh J, Samanta J. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers (Basel). 2022;14:2947. https:\/\/doi.org\/10.3390\/cancers14122947.","journal-title":"Cancers (Basel)"},{"key":"4308_CR23","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1002\/hep.30936","volume":"71","author":"L - Gouya","year":"2020","unstructured":"- Gouya L, Ventura P, Balwani M, Bissell DM, Rees DC, St\u00f6lzel U, et al. EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks. Hepatology. 2020;71:1546\u201358. https:\/\/doi.org\/10.1002\/hep.30936.","journal-title":"Hepatology"},{"key":"4308_CR24","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.amjmed.2014.06.036","volume":"127","author":"HL - Bonkovsky","year":"2014","unstructured":"- Bonkovsky HL, Maddukuri VC, Yazici C, Anderson KE, Bissell DM, Bloomer JR, et al. Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium. Am J Med. 2014;127:1233\u201341. https:\/\/doi.org\/10.1016\/j.amjmed.2014.06.036.","journal-title":"Am J Med"},{"key":"4308_CR25","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/cei.12899","volume":"187","author":"E - Storjord","year":"2017","unstructured":"- Storjord E, Dahl JA, Landsem A, Fure H, Ludviksen JK, Goldbeck-Wood S, et al. Systemic inflammation in acute intermittent porphyria: a case\u2013control study. Clin Exp Immunol. 2017;187:466\u201379. https:\/\/doi.org\/10.1111\/cei.12899.","journal-title":"Clin Exp Immunol"},{"key":"4308_CR26","doi-asserted-by":"publisher","first-page":"232470962311818","DOI":"10.1177\/23247096231181856","volume":"11","author":"A - Yusuf","year":"2023","unstructured":"- Yusuf A, Alhaj O, Aldaheri A, AlShamsi A, AlMarshoodi M, AlKindi F, et al. Rare Coexistence of Acute Intermittent Porphyria With Systemic Lupus Erythematous: Case Report and Literature Review. J Investig Med High Impact Case Rep. 2023;11:23247096231181856. https:\/\/doi.org\/10.1177\/23247096231181856.","journal-title":"J Investig Med High Impact Case Rep"},{"key":"4308_CR27","doi-asserted-by":"publisher","first-page":"9096999","DOI":"10.1155\/2022\/9096999","volume":"2022","author":"A - Liu","year":"2022","unstructured":"- Liu A, Zhou L, Zhu H, Li Y, Yang J, et al. Systemic Lupus Erythematosus and Hereditary Coproporphyria: Two Different Entities Diagnosed by WES in the Same Patient. Biomed Res Int. 2022;2022:9096999. https:\/\/doi.org\/10.1155\/2022\/9096999.","journal-title":"Biomed Res Int"},{"key":"4308_CR28","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00296-019-04500-8","volume":"40","author":"E Esteve-Valverde","year":"2020","unstructured":"Esteve-Valverde E, Tapiz-Reula A, Ruiz D, Alijotas-Reig J. Systemic lupus erythematosus and hydroxychloroquine-related acute intermittent porphyria. Rheumatol Int. 2020;40:777\u201383. https:\/\/doi.org\/10.1007\/s00296-019-04500-8.","journal-title":"Rheumatol Int"},{"key":"4308_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5582\/irdr.2020.03064","volume":"9","author":"Q - Teng","year":"2020","unstructured":"- Teng Q, Ma L, Ma Y, Zhang Y, Kang N, Hu Y, et al. The challenge of managing comorbidities: a case report of primary Sjogren\u2019s syndrome in a patient with acute intermittent porphyria. Intractable Rare Dis Res. 2020;9:137\u201340. https:\/\/doi.org\/10.5582\/irdr.2020.03064.","journal-title":"Intractable Rare Dis Res"},{"key":"4308_CR30","first-page":"37","volume":"46","author":"M -Masli\u0144ska","year":"2008","unstructured":"-Masli\u0144ska M, Jaworski J, Jan K. Coincidence of rheumatoid arthritis and acute intermittent porphyria \u2013 not an ordinary problem. A case report. Reumatologia. 2008;46:37\u20138.","journal-title":"Reumatologia"},{"key":"4308_CR31","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4274\/balkanmedj.galenos.2020.2020.4.82","volume":"37","author":"M - Y\u0131ld\u0131z","year":"2020","unstructured":"- Y\u0131ld\u0131z M, Ha\u015flak F, Adrovic A, Barut K, Kasap\u00e7opur \u00d6. Autoinflammatory Diseases in Childhood. Balkan Med J. 2020;37:236\u201346. https:\/\/doi.org\/10.4274\/balkanmedj.galenos.2020.2020.4.82.","journal-title":"Balkan Med J"},{"key":"4308_CR32","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/s0092-8674(00)80539-5","volume":"90","author":"- The International FMF Consortium","year":"1997","unstructured":"- The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797\u2013807. https:\/\/doi.org\/10.1016\/s0092-8674(00)80539-5.","journal-title":"Cell"},{"key":"4308_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/berh.2000.0089","volume":"14","author":"A - Livneh","year":"2000","unstructured":"- Livneh A, Langevitz P. Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol. 2000;14:477\u201398. https:\/\/doi.org\/10.1053\/berh.2000.0089.","journal-title":"Baillieres Best Pract Res Clin Rheumatol"},{"key":"4308_CR34","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","volume":"78","author":"M - Gattorno","year":"2019","unstructured":"- Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, et al. Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis. 2019;78:1025\u201332. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215048.","journal-title":"Ann Rheum Dis"},{"key":"4308_CR35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","volume":"128","author":"A Slobodnick","year":"2015","unstructured":"Slobodnick A, Shah B, Pillinger MH, Krasnokutsky S. Colchicine: old and new. Am J Med. 2015;128:461\u201370. https:\/\/doi.org\/10.1016\/j.amjmed.2014.12.010.","journal-title":"Am J Med"},{"key":"4308_CR36","first-page":"95","volume":"25","author":"AJ Wysenbeek","year":"1989","unstructured":"Wysenbeek AJ, Schoenfeld N, Leibovici L, Atsmon A. Colchicine treatment of abdominal pains in porphyric patients. Isr J Med Sci. 1989;25:95\u20137.","journal-title":"Isr J Med Sci"},{"key":"4308_CR37","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.cyto.2014.06.012","volume":"69","author":"JN Ibrahim","year":"2014","unstructured":"Ibrahim JN, Jounblat R, Delwail A, Abou-Ghoch J, Salem N, Chouery E, et al. Ex vivo PBMC cytokine profile in familial Mediterranean fever patients: Involvement of IL-1\u03b2, IL-1\u03b1 and Th17-associated cytokines and decrease of Th1 and Th2 cytokines. Cytokine. 2014;69:248\u201354. https:\/\/doi.org\/10.1016\/j.cyto.2014.06.012.","journal-title":"Cytokine"},{"key":"4308_CR38","doi-asserted-by":"publisher","first-page":"E4857","DOI":"10.1073\/pnas.1601700113","volume":"113","author":"W Gao","year":"2016","unstructured":"Gao W, Yang J, Liu W, Wang Y, Shao F. Site-specific phosphorylation and microtubule dynamics control Pyrin inflammasome activation. Proc Natl Acad Sci U S A. 2016;113:E4857\u201366. https:\/\/doi.org\/10.1073\/pnas.1601700113.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4308_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.mib.2020.01.005","volume":"54","author":"NA Loeven","year":"2020","unstructured":"Loeven NA, Medici NP, Bliska JB. The pyrin inflammasome in host-microbe interactions. Curr Opin Microbiol. 2020;54:77\u201386. https:\/\/doi.org\/10.1016\/j.mib.2020.01.005.","journal-title":"Curr Opin Microbiol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04308-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04308-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04308-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:29:33Z","timestamp":1781641773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04308-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4308"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04308-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was designed in accordance with the current revision of the Helsinki declaration and was approved by the local Ethical Committee of Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty (E-83045809-604.01.01-727609). Informed consent was obtained from all patients or their legal representatives for being included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all participants or their legal representatives.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}